![](/img/cover-not-exists.png)
Efficacy and safety of omalizumab (Xolair®) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial
Gastaminza, Gabriel, Azofra, Julian, Nunez-Cordoba, Jorge M., Baeza, Maria Luisa, Echechipía, Susana, Gaig, Pere, García, Blanca Esther, Labrador-Horrillo, Moises, Sala-Cunill, Ana, Brescó, Marina SabLanguage:
english
Journal:
The Journal of Allergy and Clinical Immunology: In Practice
DOI:
10.1016/j.jaip.2018.12.025
Date:
January, 2019
File:
PDF, 1.55 MB
english, 2019